PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
SELECT A FORMAT
ADD TO BASKET
BUY NOW
Provide comprehensive and accurate analysis and reports according to your exact requirements
According to this latest study, the 2021 growth of Neutropenia Biologic Drug Treatment will have significant change from previous year. By the most conservative estimates of global Neutropenia Biologic Drug Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Neutropenia Biologic Drug Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Neutropenia Biologic Drug Treatment market by product type, application, key players and key regions and countries. Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7. Filgrastim Pegfilgrastim Lenograstim Lipegfilgrastim Sargramostim Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8. Retail Pharmacies Hospital Pharmacies Online Pharmacies This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3. Teva Pharmaceutical Amgen Sanofi Mylan(Fulphila) Kyowa Kirin Novartis Spectrum Pharmaceuticals Pfizer Baxter International Partner Therapeutics(Leukine) BeyondSpring Pharmaceuticals Cellerant Therapeutics Enzychem Lifesciences Corporation Myelo Therapeutics Generon
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neutropenia Biologic Drug Treatment Market Size 2016-2026
2.1.2 Neutropenia Biologic Drug Treatment Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Neutropenia Biologic Drug Treatment Segment by Type
2.2.1 Filgrastim
2.2.2 Filgrastim
2.2.3 Lenograstim
2.2.4 Lipegfilgrastim
2.2.5 Sargramostim
2.3 Neutropenia Biologic Drug Treatment Market Size by Type
2.3.1 Global Neutropenia Biologic Drug Treatment Market Size CAGR by Type
2.3.2 Global Neutropenia Biologic Drug Treatment Market Size Market Share by Type (2016-2021)
2.4 Neutropenia Biologic Drug Treatment Segment by Application
2.4.1 Retail Pharmacies
2.4.2 Hospital Pharmacies
2.4.3 Online Pharmacies
2.5 Neutropenia Biologic Drug Treatment Market Size by Application
2.5.1 Global Neutropenia Biologic Drug Treatment Market Size CAGR by Application
2.5.2 Global Neutropenia Biologic Drug Treatment Market Size Market Share by Application (2016-2021)
3 Neutropenia Biologic Drug Treatment Market Size by Players
3.1 Neutropenia Biologic Drug Treatment Market Size Market Share by Players
3.1.1 Global Neutropenia Biologic Drug Treatment Revenue by Players (2019-2021E)
3.1.2 Global Neutropenia Biologic Drug Treatment Revenue Market Share by Players (2019-2021E)
3.2 Global Neutropenia Biologic Drug Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Neutropenia Biologic Drug Treatment by Regions
4.1 Neutropenia Biologic Drug Treatment Market Size by Regions (2016-2021)
4.2 Americas Neutropenia Biologic Drug Treatment Market Size Growth (2016-2021)
4.3 APAC Neutropenia Biologic Drug Treatment Market Size Growth (2016-2021)
4.4 Europe Neutropenia Biologic Drug Treatment Market Size Growth (2016-2021)
4.5 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Growth (2016-2021)
5 Americas
5.1 Americas Neutropenia Biologic Drug Treatment Market Size by Country (2016-2021)
5.2 Americas Neutropenia Biologic Drug Treatment Market Size by Type (2016-2021)
5.3 Americas Neutropenia Biologic Drug Treatment Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neutropenia Biologic Drug Treatment Market Size by Region (2016-2021)
6.2 APAC Neutropenia Biologic Drug Treatment Market Size by Type (2016-2021)
6.3 APAC Neutropenia Biologic Drug Treatment Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Neutropenia Biologic Drug Treatment by Country (2016-2021)
7.2 Europe Neutropenia Biologic Drug Treatment Market Size by Type (2016-2021)
7.3 Europe Neutropenia Biologic Drug Treatment Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Neutropenia Biologic Drug Treatment by Region (2016-2021)
8.2 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Type (2016-2021)
8.3 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Neutropenia Biologic Drug Treatment Market Forecast
10.1 Global Neutropenia Biologic Drug Treatment Forecast by Regions (2021-2026)
10.1.1 Global Neutropenia Biologic Drug Treatment Forecast by Regions (2021-2026)
10.1.2 Americas Neutropenia Biologic Drug Treatment Forecast
10.1.3 APAC Neutropenia Biologic Drug Treatment Forecast
10.1.4 Europe Neutropenia Biologic Drug Treatment Forecast
10.1.5 Middle East & Africa Neutropenia Biologic Drug Treatment Forecast
10.2 Americas Neutropenia Biologic Drug Treatment Forecast by Countries (2021-2026)
10.2.1 United States Neutropenia Biologic Drug Treatment Market Forecast
10.2.2 Canada Neutropenia Biologic Drug Treatment Market Forecast
10.2.3 Mexico Neutropenia Biologic Drug Treatment Market Forecast
10.2.4 Brazil Neutropenia Biologic Drug Treatment Market Forecast
10.3 APAC Neutropenia Biologic Drug Treatment Forecast by Region (2021-2026)
10.3.1 China Neutropenia Biologic Drug Treatment Market Forecast
10.3.2 Japan Neutropenia Biologic Drug Treatment Market Forecast
10.3.3 Korea Neutropenia Biologic Drug Treatment Market Forecast
10.3.4 Southeast Asia Neutropenia Biologic Drug Treatment Market Forecast
10.3.5 India Neutropenia Biologic Drug Treatment Market Forecast
10.3.6 Australia Neutropenia Biologic Drug Treatment Market Forecast
10.4 Europe Neutropenia Biologic Drug Treatment Forecast by Country (2021-2026)
10.4.1 Germany Neutropenia Biologic Drug Treatment Market Forecast
10.4.2 France Neutropenia Biologic Drug Treatment Market Forecast
10.4.3 UK Neutropenia Biologic Drug Treatment Market Forecast
10.4.4 Italy Neutropenia Biologic Drug Treatment Market Forecast
10.4.5 Russia Neutropenia Biologic Drug Treatment Market Forecast
10.5 Middle East & Africa Neutropenia Biologic Drug Treatment Forecast by Region (2021-2026)
10.5.1 Egypt Neutropenia Biologic Drug Treatment Market Forecast
10.5.2 South Africa Neutropenia Biologic Drug Treatment Market Forecast
10.5.3 Israel Neutropenia Biologic Drug Treatment Market Forecast
10.5.4 Turkey Neutropenia Biologic Drug Treatment Market Forecast
10.5.5 GCC Countries Neutropenia Biologic Drug Treatment Market Forecast
10.6 Global Neutropenia Biologic Drug Treatment Forecast by Type (2021-2026)
10.8 Global Neutropenia Biologic Drug Treatment Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Teva Pharmaceutical
11.1.1 Teva Pharmaceutical Company Information
11.1.2 Teva Pharmaceutical Neutropenia Biologic Drug Treatment Product Offered
11.1.3 Teva Pharmaceutical Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Teva Pharmaceutical Main Business Overview
11.1.5 Teva Pharmaceutical Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Neutropenia Biologic Drug Treatment Product Offered
11.2.3 Amgen Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Neutropenia Biologic Drug Treatment Product Offered
11.3.3 Sanofi Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Sanofi Main Business Overview
11.3.5 Sanofi Latest Developments
11.4 Mylan(Fulphila)
11.4.1 Mylan(Fulphila) Company Information
11.4.2 Mylan(Fulphila) Neutropenia Biologic Drug Treatment Product Offered
11.4.3 Mylan(Fulphila) Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Mylan(Fulphila) Main Business Overview
11.4.5 Mylan(Fulphila) Latest Developments
11.5 Kyowa Kirin
11.5.1 Kyowa Kirin Company Information
11.5.2 Kyowa Kirin Neutropenia Biologic Drug Treatment Product Offered
11.5.3 Kyowa Kirin Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Kyowa Kirin Main Business Overview
11.5.5 Kyowa Kirin Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Neutropenia Biologic Drug Treatment Product Offered
11.6.3 Novartis Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Spectrum Pharmaceuticals
11.7.1 Spectrum Pharmaceuticals Company Information
11.7.2 Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Product Offered
11.7.3 Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Spectrum Pharmaceuticals Main Business Overview
11.7.5 Spectrum Pharmaceuticals Latest Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Neutropenia Biologic Drug Treatment Product Offered
11.8.3 Pfizer Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Pfizer Main Business Overview
11.8.5 Pfizer Latest Developments
11.9 Baxter International
11.9.1 Baxter International Company Information
11.9.2 Baxter International Neutropenia Biologic Drug Treatment Product Offered
11.9.3 Baxter International Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Baxter International Main Business Overview
11.9.5 Baxter International Latest Developments
11.10 Partner Therapeutics(Leukine)
11.10.1 Partner Therapeutics(Leukine) Company Information
11.10.2 Partner Therapeutics(Leukine) Neutropenia Biologic Drug Treatment Product Offered
11.10.3 Partner Therapeutics(Leukine) Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Partner Therapeutics(Leukine) Main Business Overview
11.10.5 Partner Therapeutics(Leukine) Latest Developments
11.11.1 BeyondSpring Pharmaceuticals Company Information
11.11.2 BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Product Offered
11.11.3 BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 BeyondSpring Pharmaceuticals Main Business Overview
11.11.5 BeyondSpring Pharmaceuticals Latest Developments
11.12 Cellerant Therapeutics
11.12.1 Cellerant Therapeutics Company Information
11.12.2 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product Offered
11.12.3 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Cellerant Therapeutics Main Business Overview
11.12.5 Cellerant Therapeutics Latest Developments
11.13 Enzychem Lifesciences Corporation
11.13.1 Enzychem Lifesciences Corporation Company Information
11.13.2 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product Offered
11.13.3 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Enzychem Lifesciences Corporation Main Business Overview
11.13.5 Enzychem Lifesciences Corporation Latest Developments
11.14 Myelo Therapeutics
11.14.1 Myelo Therapeutics Company Information
11.14.2 Myelo Therapeutics Neutropenia Biologic Drug Treatment Product Offered
11.14.3 Myelo Therapeutics Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Myelo Therapeutics Main Business Overview
11.14.5 Myelo Therapeutics Latest Developments
11.15 Generon
11.15.1 Generon Company Information
11.15.2 Generon Neutropenia Biologic Drug Treatment Product Offered
11.15.3 Generon Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Generon Main Business Overview
11.15.5 Generon Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. Neutropenia Biologic Drug Treatment Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Filgrastim Table 3. Major Players of Pegfilgrastim Table 4. Major Players of Lenograstim Table 5. Major Players of Lipegfilgrastim Table 6. Major Players of Sargramostim Table 7. Neutropenia Biologic Drug Treatment Market Size CAGR by Type (2020-2026) & ($ Millions) Table 8. Global Neutropenia Biologic Drug Treatment Market Size by Type (2016-2021) & ($ Millions) Table 9. Global Neutropenia Biologic Drug Treatment Market Size Market Share by Type (2016-2021) Table 10. Neutropenia Biologic Drug Treatment Market Size CAGR by Application (2016-2021) & ($ Millions) Table 11. Global Neutropenia Biologic Drug Treatment Market Size by Application (2016-2021) & ($ Millions) Table 12. Global Neutropenia Biologic Drug Treatment Market Size Market Share by Application (2016-2021) Table 13. Global Neutropenia Biologic Drug Treatment Revenue by Players (2019-2021E) & ($ Millions) Table 14. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Players (2019-2021E) Table 15. Neutropenia Biologic Drug Treatment Key Players Head office and Products Offered Table 16. Neutropenia Biologic Drug Treatment Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 17. New Products and Potential Entrants Table 18. Mergers & Acquisitions, Expansion Table 19. Global Neutropenia Biologic Drug Treatment Market Size by Regions 2016-2021 & ($ Millions) Table 20. Global Neutropenia Biologic Drug Treatment Market Size Market Share by Regions 2016-2021 Table 21. Americas Neutropenia Biologic Drug Treatment Market Size by Country (2016-2021) & ($ Millions) Table 22. Americas Neutropenia Biologic Drug Treatment Market Size Market Share by Country (2016-2021) Table 23. Americas Neutropenia Biologic Drug Treatment Market Size by Type (2016-2021) & ($ Millions) Table 24. Americas Neutropenia Biologic Drug Treatment Market Size Market Share by Type (2016-2021) Table 25. Americas Neutropenia Biologic Drug Treatment Market Size by Application (2016-2021) & ($ Millions) Table 26. Americas Neutropenia Biologic Drug Treatment Market Size Market Share by Application (2016-2021) Table 27. APAC Neutropenia Biologic Drug Treatment Market Size by Region (2016-2021) & ($ Millions) Table 28. APAC Neutropenia Biologic Drug Treatment Market Size Market Share by Region (2016-2021) Table 29. APAC Neutropenia Biologic Drug Treatment Market Size by Type (2016-2021) & ($ Millions) Table 30. APAC Neutropenia Biologic Drug Treatment Market Size Market Share by Type (2016-2021) Table 31. APAC Neutropenia Biologic Drug Treatment Market Size by Application (2016-2021) & ($ Millions) Table 32. APAC Neutropenia Biologic Drug Treatment Market Size Market Share by Application (2016-2021) Table 33. Europe Neutropenia Biologic Drug Treatment Market Size by Country (2016-2021) & ($ Millions) Table 34. Europe Neutropenia Biologic Drug Treatment Market Size Market Share by Country (2016-2021) Table 35. Europe Neutropenia Biologic Drug Treatment Market Size by Type (2016-2021) & ($ Millions) Table 36. Europe Neutropenia Biologic Drug Treatment Market Size Market Share by Type (2016-2021) Table 37. Europe Neutropenia Biologic Drug Treatment Market Size by Application (2016-2021) & ($ Millions) Table 38. Europe Neutropenia Biologic Drug Treatment Market Size Market Share by Application (2016-2021) Table 39. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Region (2016-2021) & ($ Millions) Table 40. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Market Share by Region (2016-2021) Table 41. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Type (2016-2021) & ($ Millions) Table 42. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Market Share by Type (2016-2021) Table 43. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Application (2016-2021) & ($ Millions) Table 44. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Market Share by Application (2016-2021) Table 45. Key and Potential Regions of Neutropenia Biologic Drug Treatment Table 46. Key Application and Potential Industries of Neutropenia Biologic Drug Treatment Table 47. Key Challenges of Neutropenia Biologic Drug Treatment Table 48. Key Trends of Neutropenia Biologic Drug Treatment Table 49. Global Neutropenia Biologic Drug Treatment Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 50. Global Neutropenia Biologic Drug Treatment Market Size Market Share Forecast by Regions (2021-2026) Table 51. Global Neutropenia Biologic Drug Treatment Market Size Forecast by Type (2021-2026) & ($ Millions) Table 52. Global Neutropenia Biologic Drug Treatment Market Size Market Share Forecast by Type (2021-2026) Table 53. Global Neutropenia Biologic Drug Treatment Market Size Forecast by Application (2021-2026) & ($ Millions) Table 54. Global Neutropenia Biologic Drug Treatment Market Size Market Share Forecast by Application (2021-2026) Table 55. Teva Pharmaceutical Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors Table 56. Teva Pharmaceutical Neutropenia Biologic Drug Treatment Product Offered Table 57. Teva Pharmaceutical Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 58. Teva Pharmaceutical Main Business Table 59. Teva Pharmaceutical Latest Developments Table 60. Amgen Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors Table 61. Amgen Neutropenia Biologic Drug Treatment Product Offered Table 62. Amgen Main Business Table 63. Amgen Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 64. Amgen Latest Developments Table 65. Sanofi Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors Table 66. Sanofi Neutropenia Biologic Drug Treatment Product Offered Table 67. Sanofi Main Business Table 68. Sanofi Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 69. Sanofi Latest Developments Table 70. Mylan(Fulphila) Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors Table 71. Mylan(Fulphila) Neutropenia Biologic Drug Treatment Product Offered Table 72. Mylan(Fulphila) Main Business Table 73. Mylan(Fulphila) Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 74. Mylan(Fulphila) Latest Developments Table 75. Kyowa Kirin Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors Table 76. Kyowa Kirin Neutropenia Biologic Drug Treatment Product Offered Table 77. Kyowa Kirin Main Business Table 78. Kyowa Kirin Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 79. Kyowa Kirin Latest Developments Table 80. Novartis Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors Table 81. Novartis Neutropenia Biologic Drug Treatment Product Offered Table 82. Novartis Main Business Table 83. Novartis Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 84. Novartis Latest Developments Table 85. Spectrum Pharmaceuticals Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors Table 86. Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Product Offered Table 87. Spectrum Pharmaceuticals Main Business Table 88. Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 89. Spectrum Pharmaceuticals Latest Developments Table 90. Pfizer Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors Table 91. Pfizer Neutropenia Biologic Drug Treatment Product Offered Table 92. Pfizer Main Business Table 93. Pfizer Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 94. Pfizer Latest Developments Table 95. Baxter International Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors Table 96. Baxter International Neutropenia Biologic Drug Treatment Product Offered Table 97. Baxter International Main Business Table 98. Baxter International Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 99. Baxter International Latest Developments Table 100. Partner Therapeutics(Leukine) Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors Table 101. Partner Therapeutics(Leukine) Neutropenia Biologic Drug Treatment Product Offered Table 102. Partner Therapeutics(Leukine) Main Business Table 103. Partner Therapeutics(Leukine) Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 104. Partner Therapeutics(Leukine) Latest Developments Table 105. BeyondSpring Pharmaceuticals Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors Table 106. BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Product Offered Table 107. BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 108. BeyondSpring Pharmaceuticals Main Business Table 109. BeyondSpring Pharmaceuticals Latest Developments Table 110. Cellerant Therapeutics Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors Table 111. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product Offered Table 112. Cellerant Therapeutics Main Business Table 113. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 114. Cellerant Therapeutics Latest Developments Table 115. Enzychem Lifesciences Corporation Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors Table 116. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product Offered Table 117. Enzychem Lifesciences Corporation Main Business Table 118. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 119. Enzychem Lifesciences Corporation Latest Developments Table 120. Myelo Therapeutics Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors Table 121. Myelo Therapeutics Neutropenia Biologic Drug Treatment Product Offered Table 122. Myelo Therapeutics Main Business Table 123. Myelo Therapeutics Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 124. Myelo Therapeutics Latest Developments Table 125. Generon Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors Table 126. Generon Neutropenia Biologic Drug Treatment Product Offered Table 127. Generon Main Business Table 128. Generon Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 129. Generon Latest Developments List of Figures Figure 1. Neutropenia Biologic Drug Treatment Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Neutropenia Biologic Drug Treatment Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Neutropenia Biologic Drug Treatment Market Size Market Share by Type in 2020 Figure 7. Neutropenia Biologic Drug Treatment in Retail Pharmacies Figure 8. Global Neutropenia Biologic Drug Treatment Market: Retail Pharmacies (2016-2021) & ($ Millions) Figure 9. Neutropenia Biologic Drug Treatment in Hospital Pharmacies Figure 10. Global Neutropenia Biologic Drug Treatment Market: Hospital Pharmacies (2016-2021) & ($ Millions) Figure 11. Neutropenia Biologic Drug Treatment in Online Pharmacies Figure 12. Global Neutropenia Biologic Drug Treatment Market: Online Pharmacies (2016-2021) & ($ Millions) Figure 13. Global Neutropenia Biologic Drug Treatment Market Size Market Share by Application in 2020 Figure 14. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Player in 2020 Figure 15. Global Neutropenia Biologic Drug Treatment Market Size Market Share by Regions (2016-2021) Figure 16. Americas Neutropenia Biologic Drug Treatment Market Size 2016-2021 ($ Millions) Figure 17. APAC Neutropenia Biologic Drug Treatment Market Size 2016-2021 ($ Millions) Figure 18. Europe Neutropenia Biologic Drug Treatment Market Size 2016-2021 ($ Millions) Figure 19. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size 2016-2021 ($ Millions) Figure 20. Americas Neutropenia Biologic Drug Treatment Market Size Market Share by Country in 2020 Figure 21. Americas Neutropenia Biologic Drug Treatment Market Size Market Share by Type in 2020 Figure 22. Americas Neutropenia Biologic Drug Treatment Market Size Market Share by Application in 2020 Figure 23. United States Neutropenia Biologic Drug Treatment Market Size Growth 2016-2021 ($ Millions) Figure 24. Canada Neutropenia Biologic Drug Treatment Market Size Growth 2016-2021 ($ Millions) Figure 25. Mexico Neutropenia Biologic Drug Treatment Market Size Growth 2016-2021 ($ Millions) Figure 26. APAC Neutropenia Biologic Drug Treatment Market Size Market Share by Regions in 2020 Figure 27. APAC Neutropenia Biologic Drug Treatment Market Size Market Share by Type in 2020 Figure 28. APAC Neutropenia Biologic Drug Treatment Market Size Market Share by Application in 2020 Figure 29. China Neutropenia Biologic Drug Treatment Market Size Growth 2016-2021 ($ Millions) Figure 30. Japan Neutropenia Biologic Drug Treatment Market Size Growth 2016-2021 ($ Millions) Figure 31. Korea Neutropenia Biologic Drug Treatment Market Size Growth 2016-2021 ($ Millions) Figure 32. Southeast Asia Neutropenia Biologic Drug Treatment Market Size Growth 2016-2021 ($ Millions) Figure 33. India Neutropenia Biologic Drug Treatment Market Size Growth 2016-2021 ($ Millions) Figure 34. Australia Neutropenia Biologic Drug Treatment Market Size Growth 2016-2021 ($ Millions) Figure 35. Europe Neutropenia Biologic Drug Treatment Market Size Market Share by Country in 2020 Figure 36. Europe Neutropenia Biologic Drug Treatment Market Size Market Share by Type in 2020 Figure 37. Europe Neutropenia Biologic Drug Treatment Market Size Market Share by Application in 2020 Figure 38. Germany Neutropenia Biologic Drug Treatment Market Size Growth 2016-2021 ($ Millions) Figure 39. France Neutropenia Biologic Drug Treatment Market Size Growth 2016-2021 ($ Millions) Figure 40. UK Neutropenia Biologic Drug Treatment Market Size Growth 2016-2021 ($ Millions) Figure 41. Italy Neutropenia Biologic Drug Treatment Market Size Growth 2016-2021 ($ Millions) Figure 42. Russia Neutropenia Biologic Drug Treatment Market Size Growth 2016-2021 ($ Millions) Figure 43. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Market Share by Region in 2020 Figure 44. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Market Share by Type in 2020 Figure 45. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Market Share by Application in 2020 Figure 46. Egypt Neutropenia Biologic Drug Treatment Market Size Growth 2016-2021 ($ Millions) Figure 47. South Africa Neutropenia Biologic Drug Treatment Market Size Growth 2016-2021 ($ Millions) Figure 48. Israel Neutropenia Biologic Drug Treatment Market Size Growth 2016-2021 ($ Millions) Figure 49. Turkey Neutropenia Biologic Drug Treatment Market Size Growth 2016-2021 ($ Millions) Figure 50. GCC Country Neutropenia Biologic Drug Treatment Market Size Growth 2016-2021 ($ Millions) Figure 51. Americas Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 52. APAC Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 53. Europe Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 54. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 55. United States Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 56. Canada Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 57. Mexico Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 58. Brazil Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 59. China Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 60. Japan Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 61. Korea Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 62. Southeast Asia Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 63. India Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 64. Australia Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 65. Germany Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 66. France Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 67. UK Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 68. Italy Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 69. Russia Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 70. Spain Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 71. Egypt Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 72. South Africa Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 73. Israel Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 74. Turkey Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions) Figure 75. GCC Country Neutropenia Biologic Drug Treatment Market Size 2021-2026 ($ Millions)
Teva Pharmaceutical Amgen Sanofi Mylan(Fulphila) Kyowa Kirin Novartis Spectrum Pharmaceuticals Pfizer Baxter International Partner Therapeutics(Leukine) BeyondSpring Pharmaceuticals Cellerant Therapeutics Enzychem Lifesciences Corporation Myelo Therapeutics Generon
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary Source
Players/Suppliers
Industry Experts
Distributors/Traders
Opinion Leaders
Front-line Staff
Marketing Executives
Secondary Source
Journals and Periodicals
Government Bodies
Annual Reports
Presentations
Paid Databases
LPI Internal Repository
Data Synthesis
Information Gathering
Collation of Data
Estimation of Key Figures
Analysis of Derived Insights
Data Validation
Triangulation with Data Models
Reference Against Proprietary
Databases
Corroboration with Industry Experts
Qualitative Analysis
Market drivers
Market challenges
Market trends
Five forces analysis
Qualitative Analysis
Market size and forecast
Market segmentation
Geographical insights
Competitive landscape
RELATED REPORTS
Jan
2024
According to our LPI (LP Information) latest study, the global Neutropenia Biologic Drug Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Neutropenia Biologic Drug Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
$3660.00